The revenue stands at ₹7,047.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.43 per cent from ₹6,268.34 crore. This corresponds to a year-on-year *(YoY) growth of 24.23 per cent.
Operating Profit stands at ₹197.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.69 per cent from ₹170.80 crore. This corresponds to a year-on-year *(YoY) growth of 74.61 per cent.
PBDT stands at ₹838.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.14 per cent from ₹493.06 crore. This corresponds to a year-on-year *(YoY) growth of 85.48 per cent.
Profit Before Tax stands at ₹2,006.97 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.78 per cent from ₹1,415.54 crore. This corresponds to a year-on-year *(YoY) growth of 90.26 per cent.
Net Profit stands at ₹1,477.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,219.03 crore. This represents a 73.34 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | -2.33% | 1.87% | -0.60% | 9.11% | 11.42% | -0.07% |
| Torrent Pharma. | -0.84% | -1.27% | -0.59% | 3.20% | 9.02% | 23.48% |
| Cipla | -0.15% | 1.45% | -9.23% | -12.09% | -11.48% | -8.75% |
| Dr Reddy's Labs | -0.32% | 4.97% | 2.62% | 3.56% | 1.80% | 1.66% |
| Zydus Lifesci. | -1.91% | 0.98% | -0.79% | -6.25% | -7.08% | -7.94% |
| Mankind Pharma | -1.20% | -0.37% | -6.37% | -7.90% | -15.47% | -17.85% |
| Aurobindo Pharma | 0.73% | 1.37% | -0.61% | 3.30% | 13.14% | 1.22% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal